PKI Stock Recent News

PerkinElmer, Inc. (NYSE:PKI ) Q4 2022 Earnings Conference Call February 14, 2023 8:00 AM ET Company Participants Steve Willoughby - SVP, IR Prahlad Singh - President and CEO Max Krakowiak - SVP and CFO Conference Call Participants Derik de Bruin - Bank of America Patrick Donnelly - Citi Joshua Waldman - Cleveland Research Liza Garcia - UBS Dan Arias - Stifel Jack Meehan - Nephron Research Paul Knight - KeyBanc Max Masucci - Cowen Dan Leonard - Credit Suisse Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Vijay Kumar - Evercore ISI Operator Hello, and welcome to the PerkinElmer Fourth Quarter 2022 Earnings Conference Call. My name is Alex, and I'll be coordinating the call today.

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.41% and 1.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer continues to offer long-term upside potential with its management of capital and acquisitions. The economic value of its transactions has created a healthy return on investment over the time period.

PerkinElmer, Inc. (NYSE:PKI ) 41st Annual J.P. Morgan Healthcare Conference Call January 10, 2023 11:15 AM ET Company Participants Prahlad Singh - President and Chief Executive Officer Conference Call Participants Rachel Vatnsdal - JPMorgan Chase & Co. Rachel Vatnsdal Hi, everyone.

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock?

PerkinElmer's (PKI) latest launch is expected to help researchers expand options to measure viral titers, unlike ELISA and other wash-based systems.

PerkinElmer's (PKI) EONIS SCID-SMA assay kit is expected to enable early SMA and SCID screening in newborns following the FDA's approval.

PerkinElmer's (PKI) third-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, which was more than offset by lower COVID-related sales.

PerkinElmer, Inc. (NYSE:PKI ) Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President, Investor Relations Prahlad Singh - President and Chief Executive Officer Max Krakowiak - Senior Vice President and Chief Financial Officer Conference Call Participants Dan Arias - Stifel Derik de Bruin - Bank of America Jack Meehan - Nephron Research Josh Waldman - Cleveland Research Catherine Schulte - Baird Liza Garcia - UBS Matt Sykes - Goldman Sachs Vijay Kumar - Evercore ISI Max Masucci - Cowen & Co Rachel Vatnsdal - JPMorgan Operator Ladies and gentlemen, welcome to the PerkinElmer Third Quarter 2022 Earnings Call. My name is Glen, and I'm your moderator for today's call.